# Orly Vardeny

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/orly-vardeny/

## Facts

| Field | Value |
| --- | --- |
| Citations | 22,706 |
| Field | Heart Failure Treatment and Management |
| h-index | 59 |
| i10-index | 140 |
| Last Known Institution | University of Minnesota |
| OpenAlex ID | https://openalex.org/A5015556779 |
| ORCID iD | 0000-0002-6387-1351 |
| Works | 306 |

## Researcher papers

Showing 12 of 13.

- [Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction](https://scholariq.org/papers/dapagliflozin-in-heart-failure-with-mildly-reduced-or-preserved-ejection/)
- [2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure](https://scholariq.org/papers/2022-aha-acc-hfsa-guideline-for-the-management-of-heart-failure/)
- [Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19](https://scholariq.org/papers/renin-angiotensin-aldosterone-system-inhibitors-in-patients-with-covid-19/)
- [Potential Effects of Coronaviruses on the Cardiovascular System](https://scholariq.org/papers/potential-effects-of-coronaviruses-on-the-cardiovascular-system/)
- [Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure](https://scholariq.org/papers/universal-definition-and-classification-of-heart-failure-a-report-of-the-heart/)
- [2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary](https://scholariq.org/papers/2022-aha-acc-hfsa-guideline-for-the-management-of-heart-failure-executive/)
- [Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction](https://scholariq.org/papers/finerenone-in-heart-failure-with-mildly-reduced-or-preserved-ejection-fraction/)
- [Recognition and Initial Management of Fulminant Myocarditis](https://scholariq.org/papers/recognition-and-initial-management-of-fulminant-myocarditis/)
- [2022 ACC/AHA/HFSA Guideline for the Management of Heart Failure](https://scholariq.org/papers/2022-acc-aha-hfsa-guideline-for-the-management-of-heart-failure/)
- [Effects of Sacubitril-Valsartan Versus Valsartan in Women Compared With Men With Heart Failure and Preserved Ejection Fraction](https://scholariq.org/papers/effects-of-sacubitril-valsartan-versus-valsartan-in-women-compared-with-men-with/)
- [Influence of Baseline and Worsening Renal Function on Efficacy of Spironolactone in Patients With Severe Heart Failure](https://scholariq.org/papers/influence-of-baseline-and-worsening-renal-function-on-efficacy-of-spironolactone/)
- [Incidence, Predictors, and Outcomes Related to Hypo- and Hyperkalemia in Patients With Severe Heart Failure Treated With a Mineralocorticoid Receptor Antagonist](https://scholariq.org/papers/incidence-predictors-and-outcomes-related-to-hypo-and-hyperkalemia-in-patients/)

## Researcher topics

- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Influenza Virus Research Studies](https://scholariq.org/topics/influenza-virus-research-studies/)
- [Hormonal Regulation and Hypertension](https://scholariq.org/topics/hormonal-regulation-and-hypertension/)

## Researcher university

- [University of Minnesota](https://scholariq.org/institutions/university-of-minnesota/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
